National Centre for Scientific Research Demokritos, Agia Paraskevi 15341, Greece.
University of Massachusetts Medical School, Worcester, Massachusetts 01655.
J Biol Chem. 2020 May 22;295(21):7193-7210. doi: 10.1074/jbc.RA120.012976. Epub 2020 Mar 17.
Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims antigenic peptide precursors to generate mature antigenic peptides for presentation by major histocompatibility complex class I (MHCI) molecules and regulates adaptive immune responses. ERAP1 has been proposed to trim peptide precursors both in solution and in preformed MHCI-peptide complexes, but which mode is more relevant to its biological function remains controversial. Here, we compared ERAP1-mediated trimming of antigenic peptide precursors in solution or when bound to three MHCI alleles, HLA-B58, HLA-B08, and HLA-A02. For all MHCI-peptide combinations, peptide binding onto MHCI protected against ERAP1-mediated trimming. In only a single MHCI-peptide combination, trimming of an HLA-B08-bound 12-mer progressed at a considerable rate, albeit still slower than in solution. Results from thermodynamic, kinetic, and computational analyses suggested that this 12-mer is highly labile and that apparent on-MHC trimming rates are always slower than that of MHCI-peptide dissociation. Both ERAP2 and leucine aminopeptidase, an enzyme unrelated to antigen processing, could trim this labile peptide from preformed MHCI complexes as efficiently as ERAP1. A pseudopeptide analogue with high affinity for both HLA-B*08 and the ERAP1 active site could not promote the formation of a ternary ERAP1/MHCI/peptide complex. Similarly, no interactions between ERAP1 and purified peptide-loading complex were detected in the absence or presence of a pseudopeptide trap. We conclude that MHCI binding protects peptides from ERAP1 degradation and that trimming in solution along with the dynamic nature of peptide binding to MHCI are sufficient to explain ERAP1 processing of antigenic peptide precursors.
内质网氨肽酶 1(ERAP1)修剪抗原肽前体,生成成熟的抗原肽,供主要组织相容性复合体 I 类(MHCI)分子呈递,并调节适应性免疫反应。ERAP1 被提议在溶液中和预形成的 MHCI-肽复合物中修剪肽前体,但哪种模式与其生物学功能更相关仍存在争议。在这里,我们比较了 ERAP1 在溶液中或与三种 MHCI 等位基因 HLA-B58、HLA-B08 和 HLA-A02 结合时对抗原肽前体的修剪作用。对于所有的 MHCI-肽组合,肽结合到 MHCI 上都能防止 ERAP1 介导的修剪。只有在一种 MHCI-肽组合中,与 HLA-B08 结合的 12 肽的修剪以相当的速度进行,尽管仍比在溶液中慢。热力学、动力学和计算分析的结果表明,这种 12 肽非常不稳定,并且表观上的 MHC 修剪速率总是比 MHCI-肽解离的速率慢。ERAP2 和亮氨酸氨肽酶,一种与抗原加工无关的酶,都可以像 ERAP1 一样从预形成的 MHCI 复合物中修剪这种不稳定的肽。与 HLA-B*08 和 ERAP1 活性位点具有高亲和力的假肽类似物不能促进三元 ERAP1/MHCI/肽复合物的形成。同样,在没有或存在假肽陷阱的情况下,都没有检测到 ERAP1 与纯化的肽加载复合物之间的相互作用。我们的结论是,MHCI 结合保护肽免受 ERAP1 降解,并且溶液中的修剪以及肽与 MHCI 结合的动态性质足以解释 ERAP1 对抗原肽前体的加工。